These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24846067)

  • 1. MicroRNA and multiple myeloma: from laboratory findings to translational therapeutic approaches.
    Rossi M; Amodio N; Di Martino MT; Tagliaferri P; Tassone P; Cho WC
    Curr Pharm Biotechnol; 2014; 15(5):459-67. PubMed ID: 24846067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential role of miRNAs in multiple myeloma therapy.
    Caracciolo D; Montesano M; Altomare E; Scionti F; Di Martino MT; Tagliaferri P; Tassone P
    Expert Rev Hematol; 2018 Oct; 11(10):793-803. PubMed ID: 30148649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in the pathobiology of multiple myeloma.
    Lionetti M; Agnelli L; Lombardi L; Tassone P; Neri A
    Curr Cancer Drug Targets; 2012 Sep; 12(7):823-37. PubMed ID: 22671930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA deregulation in multiple myeloma.
    Bi CL; Chng WJ
    Chin Med J (Engl); 2011 Oct; 124(19):3164-9. PubMed ID: 22040573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant microRNA expression in multiple myeloma.
    Dimopoulos K; Gimsing P; Grønbæk K
    Eur J Haematol; 2013 Aug; 91(2):95-105. PubMed ID: 23586898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of microRNAs from monoclonal gammopathy of undetermined significance to multiple myeloma.
    Calvo KR; Landgren O; Roccaro AM; Ghobrial IM
    Semin Hematol; 2011 Jan; 48(1):39-45. PubMed ID: 21232657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment.
    Raimondi L; De Luca A; Morelli E; Giavaresi G; Tagliaferri P; Tassone P; Amodio N
    Biomed Res Int; 2016; 2016():6504593. PubMed ID: 26881223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario.
    Rossi M; Amodio N; Di Martino MT; Caracciolo D; Tagliaferri P; Tassone P
    Curr Drug Targets; 2013 Sep; 14(10):1144-9. PubMed ID: 23834146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of miRNA dysregulation in the pathogenesis of multiple myeloma.
    Chen D; Yang X; Liu M; Zhang Z; Xing E
    Cancer Gene Ther; 2021 Dec; 28(12):1256-1268. PubMed ID: 33402729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs and exosomes: Small molecules with big actions in multiple myeloma pathogenesis.
    Pourhanifeh MH; Mahjoubin-Tehran M; Shafiee A; Hajighadimi S; Moradizarmehri S; Mirzaei H; Asemi Z
    IUBMB Life; 2020 Mar; 72(3):314-333. PubMed ID: 31828868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation of microRNA genes in multiple myeloma.
    Wong KY; Huang X; Chim CS
    Carcinogenesis; 2012 Sep; 33(9):1629-38. PubMed ID: 22715154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA in Multiple Myeloma - A Role in Pathogenesis and Prognostic Significance.
    Puła A; Robak P; Robak T
    Curr Med Chem; 2021 Oct; 28(33):6753-6772. PubMed ID: 33949926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment.
    Botta C; Cuce M; Caracciolo D; Fiorillo L; Tagliaferri P; Tassone P
    Curr Cancer Drug Targets; 2017; 17(9):819-838. PubMed ID: 28359248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of circulating miRNAs in multiple myeloma.
    Zhang J; Xiao X; Liu J
    Sci China Life Sci; 2015 Dec; 58(12):1262-9. PubMed ID: 26607481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-21 and multiple myeloma: small molecule and big function.
    Ma J; Liu S; Wang Y
    Med Oncol; 2014 Aug; 31(8):94. PubMed ID: 24981236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Analysis of microRNA in Multiple Myeloma.
    Di Martino MT; Amodio N; Tassone P; Tagliaferri P
    Methods Mol Biol; 2016; 1375():181-94. PubMed ID: 25971914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myeloma.
    Wong KY; Chim CS
    Epigenomics; 2015; 7(6):985-1001. PubMed ID: 26417914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNAs and Multiple Myeloma: Focus on the Pathogenesis, Prognosis, and Drug Resistance.
    Tavakoli Pirzaman A; Ebrahimi P; Hasanpour AH; Shakeri M; Babajani B; Pourali Ganji Z; Babaei H; Rahmati A; Hosseinzadeh R; Doostmohamadian S; Kazemi S
    Technol Cancer Res Treat; 2023; 22():15330338231202391. PubMed ID: 37728167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant Levels of miRNAs in Bone Marrow Microenvironment and Peripheral Blood of Myeloma Patients and Disease Progression.
    Wang W; Corrigan-Cummins M; Barber EA; Saleh LM; Zingone A; Ghafoor A; Costello R; Zhang Y; Kurlander RJ; Korde N; Roccaro AM; Ghobrial IM; Landgren O; Calvo KR
    J Mol Diagn; 2015 Nov; 17(6):669-78. PubMed ID: 26433312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.